| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |